Intestinal pseudo-obstruction associated with oral morphine.
Morphine is recommended as the strong opioid of choice by the World Health Organization (WHO) for cancer pain management. It is associated with delay in gastro-intestinal transit; as a result, patients may experience marked constipation. We describe a case of intestinal pseudo-obstruction associated with the use of oral morphine in a terminally ill cancer patient.
Murthy
B V
BV
Department of Anaesthesia, Royal Liverpool University Hospital, UK.
Ion
F
F
Winstanley
J R
JR
D000284:Administration, Oral; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects*; D003248:Constipation / Q000139:chemically induced; D005772:Gastrointestinal Transit / Q000187:drug effects; D006801:Humans; D007418:Intestinal Pseudo-Obstruction / Q000139:chemically induced*; D008113:Liver Neoplasms / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage / Q000009:adverse effects*; D010146:Pain / Q000517:prevention & control; D010166:Palliative Care; D019452:Terminally Ill
D000701:Analgesics, Opioid; D009020:Morphine